These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5510364)

  • 1. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the necessity to resume and enlarge pharmacologic and clinical studies of a molecule during the advancement of its therapeutic utilization: pharmacology of trimetazidine].
    Vigne J
    Brux Med; 1970 Sep; 50(9):601-8. PubMed ID: 5510360
    [No Abstract]   [Full Text] [Related]  

  • 4. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
    Jageneau A; Schaper W
    Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies with coronary-active drugs.
    Haas H
    Brux Med; 1970 Sep; 50(9):665-8. PubMed ID: 5510369
    [No Abstract]   [Full Text] [Related]  

  • 6. The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator.
    Schaper WK; Xhoneux R; Jageneau AH; Janssen PA
    J Pharmacol Exp Ther; 1966 May; 152(2):265-74. PubMed ID: 5944369
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of hexobendine on cardiac metabolism and blood supply.
    Raberger G; Kraupp O
    Brux Med; 1970 Sep; 50(9):645-50. PubMed ID: 5510366
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epontol and coronary circulation].
    Garcia Betancourt L
    Anaesthesist; 1970 Jan; 19(1):48-51. PubMed ID: 5440158
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic bases of antiangina properties of amiodarone].
    Charlier R
    Brux Med; 1970 Sep; 50(9):651-6. PubMed ID: 5510367
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of lidoflazine in atrial muscle.
    Ilhan M; Kayaalp SO
    Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary vasodilator responses to hypoxia and induced tachycardia before and after lidoflazine.
    Afonso S
    Am J Physiol; 1969 Feb; 216(2):297-300. PubMed ID: 5766980
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of the coronary collateral circulation by lidoflazine (R 7904).
    Schaper WK; Xhonneux R; Jageneau AH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):1-8. PubMed ID: 4222721
    [No Abstract]   [Full Text] [Related]  

  • 13. [The coronary dilatator effect of various reference drugs].
    Duchene-Marullaz P; Cosnier D; Grimald J
    Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of coronary reactive hyperemia in unanesthetized pigs by an adenosine-potentiator (Lidoflazine).
    Jageneau AH; Schaper WK; Van Gerven W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):16-23. PubMed ID: 4254217
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of adenosine activity by low oral doses of lidoflazine.
    Jageneau AH; Schaper WK
    Nature; 1969 Jan; 221(5176):184-5. PubMed ID: 5782714
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of various coronary dilators following enteral application in the anesthetized dog].
    Lorenz D; Dell HD
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):272-3. PubMed ID: 4242418
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term effects of early administered sildenafil and NO donor on the cardiovascular system of SHR.
    Kristek F; Koprdová R; Cebová M
    J Physiol Pharmacol; 2007 Mar; 58(1):33-43. PubMed ID: 17440224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
    Afonso S; O'Brien GS; Berndt TB; Ansfield TJ; Rowe GG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lidoflazine derivatives with cycloaliphatic residues of coronary dilator activity].
    Carissimi M; Gentili P; Picciòla G; Ravenna F
    Farmaco Sci; 1977 Jun; 32(6):461-70. PubMed ID: 872926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of coronarotropic drugs using dipyridamole as an example.
    Kadatz R
    Brux Med; 1970 Sep; 50(9):609-16. PubMed ID: 5510361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.